Brief: Kuros Biosciences Announces Favorable Preliminary Results Of MagnetOs

Kuros Biosciences AG

31/05/2022 06:07

May 31 (Reuters) - KUROS BIOSCIENCES AG  KURN.S :
    * ANNOUNCES FAVORABLE PRELIMINARY RESULTS OF MAGNETOS AS
STANDALONE ALTERNATIVE TO AUTOGRAFT IN FIRST RANDOMIZED
CONTROLLED TRIAL
    * DATA WILL SUPPORT PRODUCT APPROVALS AT HOSPITALS AND
WITHIN
HOSPITAL SYSTEMS
    * FIRST OF FIVE PLANNED RANDOMIZED CONTROLLED TRIALS FOR
MAGNETOS
    * FUSION RATE 78%, VERSUS 42% FOR AUTOGRAFT AND 55-71% FOR
OTHER
SYNTHETIC BONE GRAFTS

Source text for Eikon:  ID:nEQ4rxcHxa 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))